SLC22A17 and Alzheimer disease: Siddiqui’s et al. (63) research showed that when the nerve growth factor (Ngfr) signal is induced and activated in the hippocampus of an AD pathological mouse model, it reduces the reactive glial state by inhibiting Lcn2/Slc22a17 signal transduction and enhances the neurotrophic function of astrocytes.